ESSA Pharma, Inc. (EPIX)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about ESSA Pharma, Inc. (EPIX)
Go deeper and ask any question about EPIX
Company Performance
Current Price
as of Sep 13, 2024$6.85
P/E Ratio
N/A
Market Cap
$303.93M
Description
ESSA Pharma, Inc. is a clinical stage pharmaceutical company. It engages in the business of developing small molecule drugs for the treatment of prostate cancer. The company was founded by Marianne D. Sadar and Raymond J. Andersen on January 6, 2009 and is headquartered in Vancouver, Canada.
Metrics
Overview
- HQVancouver, BC
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerEPIX
- Price$6.85-3.52%
Trading Information
- Market Cap$303.93M
- Float97.77%
- Average Daily Volume (1m)79,121
- Average Daily Volume (3m)50,961
- EPS-$0.63
Company
- RevenueN/A
- Rev Growth (1yr)N/A
- Net Income-$7.23M
- Gross MarginN/A
- EBITDA MarginN/A
- EBITDA-$8.62M
- EV$103.01M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
Documents
SEC Filings
Factset Street Account
Factset